Browse through our press and news section by category:

13.01.2017, Müllheim, Deutschland

Groundbreaking for SCHOTT building extension in Müllheim

Highest individual investment in a site / Expanding production capacity for the internal coating of pharmaceutical vials

Groundbreaking for SCHOTT building extension in Müllheim: Andreas Reisse (left), Executive Vice President of the Business Unit Pharmaceutical Systems, mayor of the city of Müllheim, Astrid Siemes-Knoblich, and site manager Bernhard Langner

SCHOTT AG is expanding its production capacities at its Müllheim site. An additional production line for the internal coating of pharmaceutical vials will be put into operation at the end of 2017. Today, the inaugural groundbreaking took place for the necessary new production hall that will cover an area of 600m2. The event was attended by site manager Bernhard Langner, Executive Vice President of the SCHOTT Business Unit Pharmaceutical Systems Andreas Reisse, and the mayor of the city of Müllheim, Astrid Siemes-Knoblich.

“With a high single-digit million amount, this production expansion is the highest individual investment by SCHOTT at the Müllheim site. This will allow us to improve our competitiveness in the long term,” emphasized Bernhard Langner. Andreas Reisse pointed out that Müllheim, the only German site in SCHOTT’s international network of pharmaceutical packaging plants, is an important unit for its concentration of key coating technology and its developed expertise in vial production. “Many years of experience and constant willingness to improve are important factors in our exchange of know-how with other sites,” explained the Executive Vice President of the Pharmaceutical Systems Business Unit.

The Müllheim plant currently employs around 260 people. Production focuses on high-quality glass vials for the pharmaceutical industry, which are produced from glass tubing in a complex forming process. Every year, around 300 million units leave production lines. The company also has significant expertise in the interior coating of pharmaceutical vials. The plasma coating used here is intended for filling special medications. This prevents chemical interactions between the glass surface and the drug. “With this functional coating developed by SCHOTT, we can deliver the innovative packaging solutions that the pharmaceutical industry demands,” Langner said during the ceremony.

SCHOTT is a leading international technology group in the areas of specialty glass and glass-ceramics. The company has more than 130 years of outstanding development, materials and technology expertise and offers a broad portfolio of high-quality products and intelligent solutions. SCHOTT is an innovative enabler for many industries, including the home appliance, pharma, electronics, optics, life sciences, automotive and aviation industries. SCHOTT strives to play an important part of everyone’s life and is committed to innovation and sustainable success. The group maintains a global presence with production sites and sales offices in 34 countries. With its workforce of approximately 15,000 employees, sales of 1.99 billion euros were generated in fiscal year 2015/2016. The parent company, SCHOTT AG, has its headquarters in Mainz (Germany) and is solely owned by the Carl Zeiss Foundation. As a foundation company, SCHOTT assumes special responsibility for its employees, society and the environment. www.schott.com